What is the value of EDC write-back for CROs and Phase 1 sites?

Query reduction is the primary success metric for CRO and Phase 1 site pilots. In Phase 1 oncology, every lab and every symptom can become a monitor query. When the grade lands in the EDC with the source sentence, the CTCAE criterion, the rationale, and the attribution support already attached, monitor queries decline because the evidence the monitor needs is already there. Database lock accelerates; sponsor reviews are cleaner; site capacity for new trials grows.